SCHEMBL4889402

SCHEMBL4889402

CC(C)(C)OC(=O)N1CCN(c2cccc3[nH]c(CNC(=O)OCc4ccccc4)nc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.49
HTR6 P50406 2/20 0.48
ACHE P22303 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PARP1 P09874 1/20 0.43
GRIN2B Q13224 1/20 0.42
PRMT5 O14744 3/20 0.42
MAPT P10636 2/20 0.41
KIT P10721 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SLC2A1 P11166 1/20 0.40
TLR9 Q9NR96 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4708661 0.88 HTR6 (0.46) BACE1HTR6GRIN2BMAPTALDH1A1
SCHEMBL4887610 0.81 BACE1 (0.51) BACE1ACHEMEN1KMT2AMAPT
SCHEMBL4172924 0.81 PARP1 (0.49) BACE1HTR6ACHEPARP1MAPT
SCHEMBL4899723 0.80 PARP1 (0.54) HTR6ACHEPARP1KIT
SCHEMBL4887206 0.79 BACE1 (0.51) BACE1ACHEMEN1KMT2AMAPT
SCHEMBL10004541 0.75 PARP1 (0.55) BACE1HTR6PARP1MAPTKIT
SCHEMBL23508272 0.75 TNKS (0.46) MAPTALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL4887144 0.74 RIPK1 (0.47) MAPTALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL18751212 0.73 SIGMAR1 (0.60) BACE1MEN1KMT2AP2RX7
SCHEMBL3049200 0.73 SIGMAR1 (0.60) BACE1MEN1KMT2AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214562-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-09-04 US disclosed
US-20080045537-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-02-21 US disclosed
EP-1789045-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-05-30 EP disclosed
WO-2006023400-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214562-A1 Chemical Compounds CCR5, CXCR4, CXCR3 BACE1 1860/4885HTR6 2506/4885ACHE 4784/4885
US-20080045537-A1 Chemical Compounds CCR5, CXCR4, CXCR3 BACE1 1868/4885HTR6 2334/4885ACHE 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.